BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Osmotica Pharmaceuticals plc to Provide Second Quarter 2020 Business and Financial Update and Presentation on Upneeq™ on August 11, 2020

  Company to discuss launch plans for Upneeq and will be joined by Dr. Derek Cunningham, OD, FAAO

  August 6, 2020

   · 

  1 min read
• Business

  Entasis Therapeutics Reports Second Quarter 2020 Financial Results and Business Update

  Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced its second quarter 2020 financial results and provided a business update.

  August 6, 2020

   · 

  11 min read
• Business

  Nabriva Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Updates

  Nabriva Therapeutics plc announced its financial results for the three months ended June 30, 2020 and provided a corporate update.

  August 6, 2020

   · 

  21 min read
• Business

  Progenity to Report Second Quarter 2020 Financial Results

  Progenity, Inc., a biotechnology company with an established track record of success in developing and commercializing molecular testing products, announced that it will report second quarter 2020 financial results on Thursday, August 13, 2020.

  August 6, 2020

   · 

  1 min read
• Business

  PRA Health Sciences, Inc. Reports Second Quarter 2020 Results and Provides Third Quarter and Full Year 2020 Guidance

  PRA Health Sciences, Inc. reported financial results for the quarter ended June 30, 2020.

  August 6, 2020

   · 

  18 min read
• Business

  FibroGen Reports Second Quarter 2020 Financial Results

  FibroGen, Inc. reported financial results for the second quarter of 2020 and provided an update on the company’s recent developments.

  August 6, 2020

   · 

  10 min read
• Business

  Bellicum Reports Second Quarter 2020 Financial Results and Provides Operational Update

  Bellicum Pharmaceuticals, Inc., a leader in developing novel, controllable cellular immunotherapies for cancers, reported financial results for the second quarter 2020 and provided an operational update.

  August 6, 2020

   · 

  10 min read
• Pharm Country

  SIGA Technologies, Inc. Reports Financial Results for Three and Six Months Ended June 30, 2020

  SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on the health security market, reported financial results for the three and six months ended June 30, 2020.

  August 6, 2020

   · 

  11 min read
• Business

  Guardant Health Reports Second Quarter 2020 Financial Results

  Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, reported financial results for the quarter ended June 30, 2020.

  August 6, 2020

   · 

  12 min read
• Business

  Protagonist Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update

  Protagonist Therapeutics, Inc. reported financial results for the second quarter ended June 30, 2020, and provided an update on clinical development programs.

  August 6, 2020

   · 

  10 min read